Screw Element And Segmented Barrel,Screw Element Egmented Barrel,Extruder Screw Barrels Zhoushan Dinghai Jinxing Plastic Machinery Factory , https://www.jinxingscrew.com
The report also pointed out that in the current increasingly competitive Asian companies and the United States Food and Drug Administration (FDA) to slow down the speed of approval of new chemical companies, European companies should reorganize their business, while providing the pharmaceutical industry More extensive services.
Analysts at F&S Consulting stated in the report that the restructuring of the business will inject vitality into the poorly-perceived European pharmaceutical fine chemical market. European fine chemicals companies should focus on long-term technological development and should become service providers for the pharmaceutical industry, including consulting services. ??
The report also pointed out that European fine chemical companies need to focus their development on superior technologies such as the active pharmaceutical ingredient (API) and hazardous chemicals. These companies must also strengthen customer service, improve product quality, and do their best to cooperate with Asian companies in order to maintain a long-term stable situation.
The world-renowned pharmaceutical companies Pfizer and Merck have recently undergone major business reorganization projects, and fine chemical suppliers will benefit from this. The analyst believes that this signifies the beginning of the reorganization efforts of pharmaceutical companies and will bring enormous market opportunities to the European pharmaceutical fine chemicals market. ??
F&S forecasts that the European fine chemicals market will continue to integrate. Due to the imbalance between demand and supply, some pharmaceutical fine chemical companies are undervalued, which provides private capital companies with a suitable opportunity to acquire these companies.
M&A experts in the pharmaceutical field said that Indian companies currently only purchase Western-based fine chemicals companies with small market capitalization. They have no interest in the acquisition of large-scale fine chemical companies. The main reason is that Asian companies can only be lower in Asia. Cost for production.
European refined products will reach US$13 billion in market value in three years
According to the latest research report of the Frost & Sullivan (F&S) consulting company based in London, England, the sales revenue of the European fine chemicals industry in 2005 was 10.4 billion U.S. dollars, which will continue to grow rapidly in the next few years, and the sales revenue will reach 13 billion U.S. dollars by 2009. Dollars.